Latest Proprietary Technology News

Nanollose Limited has achieved a significant milestone by blending its Nullarbor-20™ sustainable fibre with Australian merino wool to produce pilot blankets, while also completing a $672,000 placement to fund ongoing commercialisation efforts.

Vectus Biosystems advances its lead fibrosis drug VB0004 with validated Phase I safety data and strategic cost reductions, while actively pursuing licensing partnerships in China.

NoviqTech has advanced its blockchain-based sustainability solutions, pioneering real-world asset tokenisation and expanding its investor base through OTCQB trading in the US.

Australian Bond Exchange Holdings (ASX: ABE) reported a strong $3.6 billion trading volume for Q3 FY25 and announced a strategic partnership with ViewTrade Australia, while securing $1.8 million in funding to support its growth trajectory.

Wisr has upgraded its FY25 loan origination growth guidance to over 90%, driven by a 115% surge in Q3FY25 loan originations and improved credit quality metrics. The fintech lender’s disciplined growth and technology investments position it well for scaling in a shifting personal and vehicle lending market.

DataWorks Group Limited has secured a two-year extension on its BetStop self-exclusion contract and is advancing its global RegTech pipeline, aiming for positive operating cash flow by December 2025.

Harmoney has raised its FY25 cash NPAT guidance to $5.5 million and announced an on-market share buy-back, setting the stage for accelerated loan book growth and improved returns in FY26.

Aeeris Ltd delivered solid Q3 FY2025 results, driven by strong recurring revenue growth, a successful new product launch, and strategic moves to internalise key forecasting capabilities.

Corporate Travel Management Limited reported strong half-year results for the period ending December 31, 2024, with significant EBITDA growth and effective capital management, returning $52.3 million to shareholders. The company sets ambitious FY25 and FY26 targets focused on sustainable profit growth and market share expansion.

Corporate Travel Management delivered robust first-half results led by ANZ and North America, while previewing ambitious FY26 targets to double EPS within five years.

Zelira Therapeutics has received a $1.15 million cash refund from the Australian Government’s R&D Tax Incentive Scheme, bolstering its working capital to advance clinical development and business operations.

Enlitic has announced a strategic collaboration with GE HealthCare to deploy AI-driven technology that will transform the migration of medical imaging data, promising faster, more secure transitions and enhanced data quality for healthcare providers worldwide.